XML 123 R104.htm IDEA: XBRL DOCUMENT v3.24.3
EMPLOYEE STOCK PLANS - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
1 Months Ended 12 Months Ended
Jan. 31, 2017
Sep. 27, 2024
Sep. 29, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award        
Expected dividend   0.00%    
Options, grants in period, grant date fair value   $ 0.1 $ 4.0 $ 3.9
Options exercised, intrinsic value   0.0 0.1 0.5
Grant-date fair value of shares granted in the period   17.2 11.3 10.8
Shares outstanding, market value   $ 20.0 $ 24.0 $ 22.1
Employee Stock Purchase Plans        
Share-based Compensation Arrangement by Share-based Payment Award        
Expected dividend   0.00% 0.00% 0.00%
Employee Stock Option Plan        
Share-based Compensation Arrangement by Share-based Payment Award        
Compensation cost not yet recognized   $ 23.8    
Compensation cost period for recognition (in years)   1 year 10 months 24 days    
Expected dividend   0.00% 0.00% 0.00%
Minimum        
Share-based Compensation Arrangement by Share-based Payment Award        
Award expiration period (in years)   7 years    
Maximum        
Share-based Compensation Arrangement by Share-based Payment Award        
Award vesting period (in months)   48 months    
Award expiration period (in years)   10 years    
2017 ESPP | Employee Stock Purchase Plans        
Share-based Compensation Arrangement by Share-based Payment Award        
Purchase price of common stock, percent 85.00% 85.00%    
Purchase period 6 months      
Number of additional shares authorized (in shares)       0.8
Number of shares authorized (in shares)   1.8    
Stock plan offering period (in months)   6 months    
2017 ESPP | Employee Stock Option Plan        
Share-based Compensation Arrangement by Share-based Payment Award        
Number of shares available for grant (in shares)   0.3    
2020 Omnibus Stock Plan | Employee Stock Option Plan        
Share-based Compensation Arrangement by Share-based Payment Award        
Number of shares available for grant (in shares)   5.0